Evidence map›Paper›PMID 36531983›Full record

ArticleEClinicalMedicine2023

Outcomes associated with acute kidney disease: A systematic review and meta-analysis.

Ching-Chun Su, Jui-Yi Chen, Sheng-Yin Chen, Chih-Chung Shiao, Javier A Neyra, Ryo Matsuura, Eisei Noiri, Emily See, Yih-Ting Chen, Cheng-Kai Hsu and 4 more

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Macrophage-Fibroblast Crosstalk in Kidney Injury: A Narrative Review.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 4 countries.

Ching-Chun SuDivision of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Jui-Yi ChenDivision of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Sheng-Yin ChenHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Chih-Chung ShiaoDivision of Nephrology, Department of Internal Medicine, Camillian Saint Mary's Hospital Luodong; and Saint Mary's Junior College of Medicine, Nursing and Management, Yilan, Taiwan.
Javier A NeyraDepartment of Internal Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA.
Ryo MatsuuraDepartment of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
Eisei NoiriNational Center Biobank Network, National Center for Global Health and Medicine, Shinjuku, Japan.
Emily SeeDepartment of Nephrology, Royal Melbourne Hospital, Melbourne, Australia.
Yih-Ting ChenDivision of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Taiwan.
Cheng-Kai HsuDivision of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Taiwan.
Heng-Chih PanDivision of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Taiwan.
Chih-Hsiang ChangDivision of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan City, Taiwan.
Mitchell H RosnerDepartment of Medicine, University of Virginia Health System Charlottesville, VA, 22908, USA.
Vin-Cent WuDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Keelung Chang Gung Memorial Hospital · TWChi Mei Medical Center · TWChang Gung Memorial Hospital · TWHarvard University · USNational Center for Global Health and Medicine · JPNational Taiwan University Hospital · TWSaint Mary's Hospital Luodong · TWThe Royal Melbourne Hospital · AUUniversity of Alabama at Birmingham · USUniversity of Tokyo Hospital · JPUniversity of Virginia Health System · US

Funding

UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac SurgeryR01HL148448 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI FOX, AMANDA A · 2019 to 2023
$3.7M
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention TrialR01DK128208 · NIDDK · TUFTS MEDICAL CENTER · PI DREW, DAVID ALAN, NEYRA, JAVIER A. · 2021 to 2025
$1.6M
NHLBI NIH HHS R01 HL148448NIDDK NIH HHS P30 DK079337NIDDK NIH HHS R01 DK128208
6 · The paper itself

Abstract

Background: Acute kidney disease (AKD) defines the period after kidney damage and it is a critical period of both repair and fibrotic pathways. However, the outcomes of patients with AKD have not been well-defined. Methods: In this meta-analysis, PubMed, Embase, Cochrane and China National Knowledge Infrastructure were searched on July 31,2022. We excluded studies including patients undergoing kidney replacement therapy at enrollment. The data was used to conduct a random-effects model for pool outcomes between patients with AKD and non-AKD (NKD). This study is registered with PROSPERO, CRD 42021271773. Findings: The search generated 739 studies of which 21 studies were included involving 1,114,012 patients. The incidence rate of community-acquired AKD was 4.60%, 2.11% in hospital-acquired AKD without a prior AKI episode, and 26.11% in hospital-acquired AKD with a prior AKI episode. The all-cause mortality rate was higher in the AKD group (26.54%) than in the NKD group (7.78%) (odds ratio [OR]: 3.62, 95% confidence interval [CI]: 2.64 to 4.95, p < 0.001, I Interpretation: AKD is common in community and hospitalized patients who suffer from AKI and also occurs in patients without prior AKI. The patients with AKD, also in those without prior AKI had a higher risk of mortality, and new-onset ESKD than the NKD group. Funding: This study was supported by Ministry of Science and Technology (MOST) of the Republic of China (Taiwan) [grant number, MOST 107-2314-B-002-026-MY3, 108-2314-B-002-058, 110-2314-B-002-241, 110-2314-B-002-239], National Science and Technology Council (NSTC) [grant number, NSTC 109-2314-B-002-174-MY3, 110-2314-B-002-124-MY3, 111-2314-B-002-046, 111-2314-B-002-058], National Health Research Institutes [PH-102-SP-09], National Taiwan University Hospital [109-S4634, PC-1246, PC-1309, VN109-09, UN109-041, UN110-030, 111-FTN0011] Grant MOHW110-TDU-B-212-124005, Mrs. Hsiu-Chin Lee Kidney Research Fund and Chi-mei medical center CMFHR11136. JAN is supported, in part, by grants from the National Institute of Health, NIDDK (R01 DK128208 and P30 DK079337) and NHLBI (R01 HL148448-01).

Indexed as

Acute kidney diseaseAcute kidney injuryChronic kidney diseaseEnd-stage kidney disease

Identifiers

PMID36531983
PMCPMC9755056
OpenAlexW4311240531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.